Condition: Alzheimer s Disease · Alzheimer Dementia · Alzheimer Dementia (AD) · Sponsor: Sunnybrook Health Sciences Centre
This pilot study will evaluate the safety and tolerability of the natural health product, fisetin, in older adults with mild cognitive impairment or mild Alzheimer's disease dementia.
This description comes directly from the study's public registry record.
Study Coordinator · 416-480-6100 · memoryresearch@sunnybrook.ca
Always discuss trial participation with your own doctor first.
| Sunnybrook Research Institute | Toronto, Ontario, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07279714